1. 307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study. (10th December 2020) Authors: Lewis, Karl; Ascierto, Paolo; Robert, Caroline; Munhoz, Rodrigo; Liszkay, Gabriella; Marino, Luis De La Cruz; Olah, Judit; Queirolo, Paola; Mackiewicz, Jacek; Shah, Kalpit; Forbes, Harper; Hertig, Christian; Yan, Yibing; Gutzmer, Ralf; McArthur, Grant Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 307 Atezolizumab plus vemurafenib and cobimetinib provides favorable survival outcomes in patients with high tumor mutation burden and proinflammatory gene signature in the phase 3 IMspire150 study. (9th November 2020) Authors: Lewis, Karl; Ascierto, Paolo; Robert, Caroline; Munhoz, Rodrigo; Liszkay, Gabriella; Marino, Luis De La Cruz; Olah, Judit; Queirolo, Paola; Mackiewicz, Jacek; Shah, Kalpit; Forbes, Harper; Hertig, Christian; Yan, Yibing; Gutzmer, Ralf; McArthur, Grant Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program. Issue 1 (8th April 2020) Authors: Walker, John W; Lebbé, Celeste; Grignani, Giovanni; Nathan, Paul; Dirix, Luc; Fenig, Eyal; Ascierto, Paolo Antonio; Sandhu, Shahneen; Munhoz, Rodrigo; Benincasa, Elena; Flaskett, Sarah; Reed, Josh; Engelsberg, Arne; Hariharan, Subramanian; Kasturi, Vijay Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inter‐ and intra‐patient heterogeneity of PD‐L1 expression in metastatic melanomas: A retrospective study. (20th November 2020) Authors: Giavina‐Bianchi, Mara; Nacagamo Sotto, Mirian; Giavina‐Bianchi, Pedro; Munhoz, Rodrigo; Festa Neto, Cyro; Kalil, Jorge Journal: Australasian journal of dermatology Issue: Volume 62:Number 2(2021) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗